Modelling Mutation in Equine Infectious Anemia Virus Infection Suggests a Path to Viral Clearance with Repeated Vaccination
Equine infectious anemia virus (EIAV) is a lentivirus similar to
HIV that infects horses. Clinical and experimental studies demonstrating immune
control of EIAV infection hold promise for efforts to produce an HIV vaccine. Antibody
infusions have been shown to block both wild-type and mutant virus
infection, but the mutant sometimes escapes. Using these data, we develop a mathematical
model that describes the interactions between antibodies and both wild-type and
mutant virus populations, in the context of continual virus mutation. The aim of this
work is to determine whether repeated vaccinations through antibody infusions can
reduce both the wild-type and mutant strains of the virus below one viral particle,
and if so, to examine the vaccination period and number of infusions that ensure
eradication. The antibody infusions are modelled using impulsive differential equations, a
technique that offers insight into repeated vaccination by approximating the
time-to-peak by an instantaneous change. We use impulsive theory to
determine the maximal vaccination intervals that would be required to reduce the
wild-type and mutant virus levels below one particle per horse. We show that seven
boosts of the antibody vaccine are sufficient to eradicate both the wild-type and the
mutant strains. In the case of a mutant virus infection that is given infusions of
antibodies targeting wild-type virus (i.e., simulation of a heterologous
infection), seven infusions were likewise sufficient to eradicate infection, based
upon the data set. However, if the period between infusions was sufficiently increased,
both the wild-type and mutant virus would eventually persist in the form of a
periodic orbit. These results suggest a route forward to design antibody-based vaccine
strategies to control viruses subject to mutant escape.